Endostatin and Oxaliplatin‐Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study

LESSONS LEARNED. Definitive concurrent chemoradiotherapy based on oxaliplatin and endostatin was effective with the objective response rate exceeding 80%, and the treatment‐related toxicities were acceptable. The treatment compliance of the current combination was much higher, without significant re...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenxin, Chen, Peng, Zhang, Ni, Song, Tao, Wu, Shixiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459259/
https://www.ncbi.nlm.nih.gov/pubmed/30850562
http://dx.doi.org/10.1634/theoncologist.2019-0119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459259/
https://www.ncbi.nlm.nih.gov/pubmed/30850562
http://dx.doi.org/10.1634/theoncologist.2019-0119

Ejemplares similares